USPTO serial 90028892
SCIENSUS
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 23, 2021
- Examiner
- PURATH, ANICKA S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SCIENSUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,842*
Plus Government fees of $2,600
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
SCIENSUS PHARMA SERVICES LIMITED
STAFFORDSHIRE, GB
Staffordshire, GB
Staffordshire, GB
Staffordshire, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Christine Lebron-Dykeman
Christine Lebron-Dykeman MCKEE, VOORHEES & SEASE, P.L.C.801 GRAND AVENUE, SUITE 3200DES MOINES, IA 50309-2721UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; medicines, namely oral and injectable medicines for the treatment of rare diseases and orphan diseases; pharmaceutical preparations for the treatment of MS, anaemia, schizophrenia, pneumonia, fertility, blood disorder, cystic fibrosis, GEP tumours, hepatitis B and C, lung disease; sanitary preparations for medical purposes; medical dressings, medical plasters, materials being gauze for dressings | ACTIVE | — |
| 009 | Downloadable computer software for monitoring patient health, analyzing medical and healthcare data, accessing medical data, managing medical records, and customizing treatment plans; downloadable health monitoring software; downloadable software in the nature of a health monitoring mobile application; downloadable educational software relating to healthcare, namely, software featuring instruction in the field of healthcare for patients and clinicians; downloadable software in the nature of an educational mobile application relating to healthcare for patients and clinicians; downloadable computer software for analyzing medical and healthcare data and accessing medical records for use in medical decision support systems; downloadable computer software using artificial intelligence for healthcare, namely, software for accessing and analyzing medical and healthcare data using machine learning algorithms; downloadable virtual reality software for medical teaching; downloadable software for analysis of medical and healthcare data | ACTIVE | — |
| 010 | Physical therapy and rehabilitation equipment, namely, foam rollers, manually-operated operated exercise equipment, resistance bands, weights, weighted balls; orthopaedic and mobility aids, namely, walkers, orthopedic braces, orthopedic supports; massage apparatus; medical apparatus and instruments for monitoring vital signs, blood properties and for treatment of viral and infectious diseases, for the treatment of cancer, and for the treatment of rare diseases and orphan diseases, Multiple Sclerosis (MS), anaemia, schizophrenia, pneumonia, fertility, blood disorder, cystic fibrosis, Gastroenteropancreatic (GEP) tumours, hepatitis B and C, lung disease; medical furniture and bedding, namely, furniture, blankets, and air pillows for medical purposes; equipment for moving patients, namely, low friction pads for sliding patients to or from a stretcher and bed, gurneys, patient lifting hoists | ACTIVE | — |
| 035 | Data collection services for business purposes; market research data collection; provision of business statistical information relating to medical matters | ACTIVE | — |
| 038 | Electronic data exchange services, namely, electronic exchange of medical records across a nationwide health information network; telecommunications information; electronic data transmission; data transfer by telecommunications services; communications services for the exchange of data in electronic form, namely, providing access to an electronic exchange of medical records across a nationwide health information network; electronic exchange of data stored in databases accessible via telecommunication networks; electronic data exchange and transfer services for the healthcare, pharmaceutical and medical industry | ACTIVE | — |
| 039 | Arranging the distribution of pharmaceuticals; distribution and storage services, namely, storage and delivery of pharmaceuticals and medical preparations; storage of pharmaceuticals; transportation of pharmaceuticals; delivery of pharmaceutical and medical preparations | ACTIVE | — |
| 042 | Conducting clinic trials for others; medical research services; scientific research in the field of pharmacy; pharmacological research services; Temporary electronic data storage; electronic data storage services; electronic data storage services for the healthcare, pharmaceutical and medical industry; compilation of statistical data relating to medical research | ACTIVE | — |
| 044 | Healthcare services; pharmaceutical services, namely, dispensing of pharmaceuticals, pharmaceutical advice, pharmaceutical compounding services; medical services; dentistry services; health assessment services; health care services in domestic homes; healthcare consultancy in the field of viral and infectious diseases, for the treatment of cancer and for the treatment of rare diseases and orphan diseases; medical analysis for the diagnosis and treatment of persons including x-ray examinations and taking blood samples; pharmacy advice, namely, providing advice relating to preparation of prescriptions in pharmacies; provision of nursing care; pharmaceutical advisory services, namely, pharmaceutical advice; health care services, namely, collation of information in the healthcare sector relating to the use of pharmaceutical products and patient-medication behaviour for treatment and diagnostic purposes; medical clinical services; healthcare services, namely, development and design of home health care plans and packages in the nature of developing and providing personal home health care assessments and personalized home health care routines, maintenance schedules, and counseling; pharmacists' services to make up prescriptions; medical analysis services for the treatment of patients; providing healthcare information by telephone; home healthcare services; home nursing aid services; provision of health care services in domestic homes; outpatient and inpatient care services; provision of medical treatment of viral and infectious diseases, for the treatment of cancer, and for the treatment of rare diseases and orphan diseases, Multiple Sclerosis (MS), anaemia, schizophrenia, pneumonia, fertility, blood disorder, cystic fibrosis, Gastroenteropancreatic (GEP) tumours, hepatitis B and C, lung disease; medical and healthcare information services; maintaining personal medical history records and files | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by SCIENSUS PHARMA SERVICES LIMITED
- Other trademarks owned by Healthcare at Home Limited
- Other trademarks owned by Healthcare at Home Limited
- Other trademarks owned by Healthcare at Home Limited
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 035
- Other trademarks in Class 038
- Other trademarks in Class 039
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SCIENSUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jun 22, 2022 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Nov 23, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 18, 2021 | DP1B | 1(B) BASIS DELETED; PROCEED TO REGISTRATION | — |
| Oct 18, 2021 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 30, 2021 | IUCN | NOTICE OF ALLOWANCE CANCELLED | — |
| Sep 30, 2021 | D1BR | TEAS DELETE 1(B) BASIS RECEIVED | — |
| Jul 20, 2021 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 25, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| May 25, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 5, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 20, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 20, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 20, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Apr 20, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Apr 20, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Apr 9, 2021 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2021 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 9, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 5, 2021 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Mar 9, 2021 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| Feb 23, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Feb 22, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Feb 22, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Feb 22, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Feb 22, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Feb 18, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Feb 18, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Feb 18, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 9, 2020 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2020 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 9, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 2, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 28, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 3, 2020 | NWAP | NEW APPLICATION ENTERED | — |